nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurbiprofen—Ibuprofen—Melphalan—peripheral nervous system neoplasm	0.33	0.702	CrCrCtD
Flurbiprofen—L-Phenylalanine—Melphalan—peripheral nervous system neoplasm	0.14	0.298	CrCrCtD
Flurbiprofen—UGT2B7—Epirubicin—peripheral nervous system neoplasm	0.0907	0.303	CbGbCtD
Flurbiprofen—UGT1A1—Etoposide—peripheral nervous system neoplasm	0.0611	0.204	CbGbCtD
Flurbiprofen—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.0374	0.125	CbGbCtD
Flurbiprofen—PTGS2—Etoposide—peripheral nervous system neoplasm	0.0367	0.123	CbGbCtD
Flurbiprofen—PTGS1—Etoposide—peripheral nervous system neoplasm	0.031	0.104	CbGbCtD
Flurbiprofen—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0297	0.0991	CbGbCtD
Flurbiprofen—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0127	0.0424	CbGbCtD
Flurbiprofen—L-Phenylalanine—TH—peripheral nervous system neoplasm	0.00107	0.755	CrCbGaD
Flurbiprofen—Ibuprofen—ABCB1—peripheral nervous system neoplasm	0.00014	0.0987	CrCbGaD
Flurbiprofen—Nitrazepam—ABCB1—peripheral nervous system neoplasm	0.000121	0.0856	CrCbGaD
Flurbiprofen—Infection—Etoposide—peripheral nervous system neoplasm	9.35e-05	0.000408	CcSEcCtD
Flurbiprofen—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	9.34e-05	0.000407	CcSEcCtD
Flurbiprofen—Ataxia—Doxorubicin—peripheral nervous system neoplasm	9.34e-05	0.000407	CcSEcCtD
Flurbiprofen—Asthenia—Dactinomycin—peripheral nervous system neoplasm	9.33e-05	0.000407	CcSEcCtD
Flurbiprofen—Nausea—Melphalan—peripheral nervous system neoplasm	9.33e-05	0.000407	CcSEcCtD
Flurbiprofen—Asthma—Epirubicin—peripheral nervous system neoplasm	9.28e-05	0.000404	CcSEcCtD
Flurbiprofen—Influenza—Epirubicin—peripheral nervous system neoplasm	9.28e-05	0.000404	CcSEcCtD
Flurbiprofen—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	9.23e-05	0.000402	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	9.22e-05	0.000402	CcSEcCtD
Flurbiprofen—Tachycardia—Etoposide—peripheral nervous system neoplasm	9.19e-05	0.0004	CcSEcCtD
Flurbiprofen—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	9.19e-05	0.0004	CcSEcCtD
Flurbiprofen—Abdominal pain—Vincristine—peripheral nervous system neoplasm	9.19e-05	0.0004	CcSEcCtD
Flurbiprofen—Body temperature increased—Vincristine—peripheral nervous system neoplasm	9.19e-05	0.0004	CcSEcCtD
Flurbiprofen—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	9.16e-05	0.000399	CcSEcCtD
Flurbiprofen—Dry skin—Doxorubicin—peripheral nervous system neoplasm	9.11e-05	0.000397	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	9.1e-05	0.000397	CcSEcCtD
Flurbiprofen—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	9.1e-05	0.000396	CcSEcCtD
Flurbiprofen—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	9.04e-05	0.000394	CcSEcCtD
Flurbiprofen—Anorexia—Etoposide—peripheral nervous system neoplasm	8.97e-05	0.000391	CcSEcCtD
Flurbiprofen—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	8.95e-05	0.00039	CcSEcCtD
Flurbiprofen—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	8.93e-05	0.000389	CcSEcCtD
Flurbiprofen—Bronchitis—Epirubicin—peripheral nervous system neoplasm	8.92e-05	0.000389	CcSEcCtD
Flurbiprofen—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	8.9e-05	0.000388	CcSEcCtD
Flurbiprofen—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	8.89e-05	0.000387	CcSEcCtD
Flurbiprofen—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	8.81e-05	0.000384	CcSEcCtD
Flurbiprofen—Hypotension—Etoposide—peripheral nervous system neoplasm	8.8e-05	0.000383	CcSEcCtD
Flurbiprofen—Gastritis—Doxorubicin—peripheral nervous system neoplasm	8.79e-05	0.000383	CcSEcCtD
Flurbiprofen—Pain—Cisplatin—peripheral nervous system neoplasm	8.79e-05	0.000383	CcSEcCtD
Flurbiprofen—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	8.76e-05	0.000382	CcSEcCtD
Flurbiprofen—Dysuria—Epirubicin—peripheral nervous system neoplasm	8.68e-05	0.000378	CcSEcCtD
Flurbiprofen—Neutropenia—Epirubicin—peripheral nervous system neoplasm	8.68e-05	0.000378	CcSEcCtD
Flurbiprofen—Asthenia—Alitretinoin—peripheral nervous system neoplasm	8.65e-05	0.000377	CcSEcCtD
Flurbiprofen—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	8.64e-05	0.000377	CcSEcCtD
Flurbiprofen—Asthma—Doxorubicin—peripheral nervous system neoplasm	8.59e-05	0.000374	CcSEcCtD
Flurbiprofen—Influenza—Doxorubicin—peripheral nervous system neoplasm	8.59e-05	0.000374	CcSEcCtD
Flurbiprofen—Diazepam—ABCB1—peripheral nervous system neoplasm	8.58e-05	0.0604	CrCbGaD
Flurbiprofen—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	8.56e-05	0.000373	CcSEcCtD
Flurbiprofen—Pruritus—Alitretinoin—peripheral nervous system neoplasm	8.53e-05	0.000372	CcSEcCtD
Flurbiprofen—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	8.5e-05	0.00037	CcSEcCtD
Flurbiprofen—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	8.47e-05	0.000369	CcSEcCtD
Flurbiprofen—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	8.47e-05	0.000369	CcSEcCtD
Flurbiprofen—Paraesthesia—Etoposide—peripheral nervous system neoplasm	8.45e-05	0.000368	CcSEcCtD
Flurbiprofen—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	8.42e-05	0.000367	CcSEcCtD
Flurbiprofen—Dyspnoea—Etoposide—peripheral nervous system neoplasm	8.39e-05	0.000366	CcSEcCtD
Flurbiprofen—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	8.37e-05	0.000365	CcSEcCtD
Flurbiprofen—Somnolence—Etoposide—peripheral nervous system neoplasm	8.37e-05	0.000365	CcSEcCtD
Flurbiprofen—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	8.36e-05	0.000364	CcSEcCtD
Flurbiprofen—Asthenia—Vincristine—peripheral nervous system neoplasm	8.34e-05	0.000363	CcSEcCtD
Flurbiprofen—Pneumonia—Epirubicin—peripheral nervous system neoplasm	8.32e-05	0.000363	CcSEcCtD
Flurbiprofen—Drowsiness—Epirubicin—peripheral nervous system neoplasm	8.27e-05	0.000361	CcSEcCtD
Flurbiprofen—Vomiting—Dactinomycin—peripheral nervous system neoplasm	8.27e-05	0.00036	CcSEcCtD
Flurbiprofen—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	8.26e-05	0.00036	CcSEcCtD
Flurbiprofen—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	8.25e-05	0.00036	CcSEcCtD
Flurbiprofen—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	8.2e-05	0.000357	CcSEcCtD
Flurbiprofen—Rash—Dactinomycin—peripheral nervous system neoplasm	8.2e-05	0.000357	CcSEcCtD
Flurbiprofen—Decreased appetite—Etoposide—peripheral nervous system neoplasm	8.18e-05	0.000357	CcSEcCtD
Flurbiprofen—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	8.15e-05	0.000355	CcSEcCtD
Flurbiprofen—Renal failure—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.000354	CcSEcCtD
Flurbiprofen—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	8.12e-05	0.000354	CcSEcCtD
Flurbiprofen—Stomatitis—Epirubicin—peripheral nervous system neoplasm	8.06e-05	0.000351	CcSEcCtD
Flurbiprofen—Jaundice—Epirubicin—peripheral nervous system neoplasm	8.06e-05	0.000351	CcSEcCtD
Flurbiprofen—Constipation—Etoposide—peripheral nervous system neoplasm	8.05e-05	0.000351	CcSEcCtD
Flurbiprofen—Pain—Etoposide—peripheral nervous system neoplasm	8.05e-05	0.000351	CcSEcCtD
Flurbiprofen—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	8.04e-05	0.00035	CcSEcCtD
Flurbiprofen—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	8.04e-05	0.00035	CcSEcCtD
Flurbiprofen—Dysuria—Doxorubicin—peripheral nervous system neoplasm	8.03e-05	0.00035	CcSEcCtD
Flurbiprofen—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	8.03e-05	0.00035	CcSEcCtD
Flurbiprofen—Dizziness—Alitretinoin—peripheral nervous system neoplasm	7.97e-05	0.000348	CcSEcCtD
Flurbiprofen—Diarrhoea—Vincristine—peripheral nervous system neoplasm	7.95e-05	0.000347	CcSEcCtD
Flurbiprofen—Sweating—Epirubicin—peripheral nervous system neoplasm	7.93e-05	0.000346	CcSEcCtD
Flurbiprofen—Haematuria—Epirubicin—peripheral nervous system neoplasm	7.89e-05	0.000344	CcSEcCtD
Flurbiprofen—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	7.84e-05	0.000342	CcSEcCtD
Flurbiprofen—Epistaxis—Epirubicin—peripheral nervous system neoplasm	7.8e-05	0.00034	CcSEcCtD
Flurbiprofen—Sinusitis—Epirubicin—peripheral nervous system neoplasm	7.76e-05	0.000338	CcSEcCtD
Flurbiprofen—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	7.76e-05	0.000338	CcSEcCtD
Flurbiprofen—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	7.75e-05	0.000338	CcSEcCtD
Flurbiprofen—Nausea—Dactinomycin—peripheral nervous system neoplasm	7.73e-05	0.000337	CcSEcCtD
Flurbiprofen—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	7.72e-05	0.000336	CcSEcCtD
Flurbiprofen—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	7.7e-05	0.000336	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	7.7e-05	0.000335	CcSEcCtD
Flurbiprofen—Dizziness—Vincristine—peripheral nervous system neoplasm	7.68e-05	0.000335	CcSEcCtD
Flurbiprofen—Vomiting—Alitretinoin—peripheral nervous system neoplasm	7.67e-05	0.000334	CcSEcCtD
Flurbiprofen—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	7.66e-05	0.000334	CcSEcCtD
Flurbiprofen—Rash—Alitretinoin—peripheral nervous system neoplasm	7.6e-05	0.000331	CcSEcCtD
Flurbiprofen—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	7.6e-05	0.000331	CcSEcCtD
Flurbiprofen—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	7.59e-05	0.000331	CcSEcCtD
Flurbiprofen—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	7.57e-05	0.00033	CcSEcCtD
Flurbiprofen—Headache—Alitretinoin—peripheral nervous system neoplasm	7.56e-05	0.000329	CcSEcCtD
Flurbiprofen—Renal failure—Doxorubicin—peripheral nervous system neoplasm	7.53e-05	0.000328	CcSEcCtD
Flurbiprofen—Urticaria—Etoposide—peripheral nervous system neoplasm	7.48e-05	0.000326	CcSEcCtD
Flurbiprofen—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	7.47e-05	0.000325	CcSEcCtD
Flurbiprofen—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	7.46e-05	0.000325	CcSEcCtD
Flurbiprofen—Jaundice—Doxorubicin—peripheral nervous system neoplasm	7.46e-05	0.000325	CcSEcCtD
Flurbiprofen—Rhinitis—Epirubicin—peripheral nervous system neoplasm	7.45e-05	0.000324	CcSEcCtD
Flurbiprofen—Abdominal pain—Etoposide—peripheral nervous system neoplasm	7.44e-05	0.000324	CcSEcCtD
Flurbiprofen—Body temperature increased—Etoposide—peripheral nervous system neoplasm	7.44e-05	0.000324	CcSEcCtD
Flurbiprofen—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	7.44e-05	0.000324	CcSEcCtD
Flurbiprofen—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	7.44e-05	0.000324	CcSEcCtD
Flurbiprofen—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	7.43e-05	0.000324	CcSEcCtD
Flurbiprofen—Hepatitis—Epirubicin—peripheral nervous system neoplasm	7.43e-05	0.000324	CcSEcCtD
Flurbiprofen—Vomiting—Vincristine—peripheral nervous system neoplasm	7.39e-05	0.000322	CcSEcCtD
Flurbiprofen—Asthenia—Cisplatin—peripheral nervous system neoplasm	7.37e-05	0.000321	CcSEcCtD
Flurbiprofen—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	7.37e-05	0.000321	CcSEcCtD
Flurbiprofen—Sweating—Doxorubicin—peripheral nervous system neoplasm	7.34e-05	0.00032	CcSEcCtD
Flurbiprofen—Rash—Vincristine—peripheral nervous system neoplasm	7.33e-05	0.000319	CcSEcCtD
Flurbiprofen—Dermatitis—Vincristine—peripheral nervous system neoplasm	7.32e-05	0.000319	CcSEcCtD
Flurbiprofen—Haematuria—Doxorubicin—peripheral nervous system neoplasm	7.3e-05	0.000318	CcSEcCtD
Flurbiprofen—Headache—Vincristine—peripheral nervous system neoplasm	7.28e-05	0.000317	CcSEcCtD
Flurbiprofen—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	7.22e-05	0.000315	CcSEcCtD
Flurbiprofen—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	7.18e-05	0.000313	CcSEcCtD
Flurbiprofen—Nausea—Alitretinoin—peripheral nervous system neoplasm	7.16e-05	0.000312	CcSEcCtD
Flurbiprofen—Visual impairment—Epirubicin—peripheral nervous system neoplasm	7.16e-05	0.000312	CcSEcCtD
Flurbiprofen—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	7.14e-05	0.000311	CcSEcCtD
Flurbiprofen—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	7.03e-05	0.000306	CcSEcCtD
Flurbiprofen—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	7.02e-05	0.000306	CcSEcCtD
Flurbiprofen—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	6.94e-05	0.000302	CcSEcCtD
Flurbiprofen—Tinnitus—Epirubicin—peripheral nervous system neoplasm	6.93e-05	0.000302	CcSEcCtD
Flurbiprofen—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	6.91e-05	0.000301	CcSEcCtD
Flurbiprofen—Nausea—Vincristine—peripheral nervous system neoplasm	6.9e-05	0.000301	CcSEcCtD
Flurbiprofen—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	6.89e-05	0.0003	CcSEcCtD
Flurbiprofen—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	6.87e-05	0.000299	CcSEcCtD
Flurbiprofen—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	6.87e-05	0.000299	CcSEcCtD
Flurbiprofen—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	6.82e-05	0.000297	CcSEcCtD
Flurbiprofen—Asthenia—Etoposide—peripheral nervous system neoplasm	6.75e-05	0.000294	CcSEcCtD
Flurbiprofen—Angiopathy—Epirubicin—peripheral nervous system neoplasm	6.74e-05	0.000294	CcSEcCtD
Flurbiprofen—Chills—Epirubicin—peripheral nervous system neoplasm	6.66e-05	0.00029	CcSEcCtD
Flurbiprofen—Pruritus—Etoposide—peripheral nervous system neoplasm	6.66e-05	0.00029	CcSEcCtD
Flurbiprofen—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	6.64e-05	0.000289	CcSEcCtD
Flurbiprofen—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	6.62e-05	0.000289	CcSEcCtD
Flurbiprofen—Alopecia—Epirubicin—peripheral nervous system neoplasm	6.56e-05	0.000286	CcSEcCtD
Flurbiprofen—Vomiting—Cisplatin—peripheral nervous system neoplasm	6.53e-05	0.000285	CcSEcCtD
Flurbiprofen—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	6.5e-05	0.000283	CcSEcCtD
Flurbiprofen—Rash—Cisplatin—peripheral nervous system neoplasm	6.48e-05	0.000282	CcSEcCtD
Flurbiprofen—Dermatitis—Cisplatin—peripheral nervous system neoplasm	6.47e-05	0.000282	CcSEcCtD
Flurbiprofen—Diarrhoea—Etoposide—peripheral nervous system neoplasm	6.44e-05	0.000281	CcSEcCtD
Flurbiprofen—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	6.41e-05	0.000279	CcSEcCtD
Flurbiprofen—Flatulence—Epirubicin—peripheral nervous system neoplasm	6.37e-05	0.000278	CcSEcCtD
Flurbiprofen—Tension—Epirubicin—peripheral nervous system neoplasm	6.34e-05	0.000276	CcSEcCtD
Flurbiprofen—Nervousness—Epirubicin—peripheral nervous system neoplasm	6.28e-05	0.000274	CcSEcCtD
Flurbiprofen—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	6.24e-05	0.000272	CcSEcCtD
Flurbiprofen—Dizziness—Etoposide—peripheral nervous system neoplasm	6.23e-05	0.000271	CcSEcCtD
Flurbiprofen—Chills—Doxorubicin—peripheral nervous system neoplasm	6.17e-05	0.000269	CcSEcCtD
Flurbiprofen—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	6.14e-05	0.000268	CcSEcCtD
Flurbiprofen—Nausea—Cisplatin—peripheral nervous system neoplasm	6.1e-05	0.000266	CcSEcCtD
Flurbiprofen—Alopecia—Doxorubicin—peripheral nervous system neoplasm	6.07e-05	0.000265	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	6e-05	0.000261	CcSEcCtD
Flurbiprofen—Vomiting—Etoposide—peripheral nervous system neoplasm	5.99e-05	0.000261	CcSEcCtD
Flurbiprofen—Anaemia—Epirubicin—peripheral nervous system neoplasm	5.98e-05	0.00026	CcSEcCtD
Flurbiprofen—Rash—Etoposide—peripheral nervous system neoplasm	5.94e-05	0.000259	CcSEcCtD
Flurbiprofen—Dermatitis—Etoposide—peripheral nervous system neoplasm	5.93e-05	0.000258	CcSEcCtD
Flurbiprofen—Headache—Etoposide—peripheral nervous system neoplasm	5.9e-05	0.000257	CcSEcCtD
Flurbiprofen—Flatulence—Doxorubicin—peripheral nervous system neoplasm	5.9e-05	0.000257	CcSEcCtD
Flurbiprofen—Tension—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.000256	CcSEcCtD
Flurbiprofen—Malaise—Epirubicin—peripheral nervous system neoplasm	5.83e-05	0.000254	CcSEcCtD
Flurbiprofen—Nervousness—Doxorubicin—peripheral nervous system neoplasm	5.81e-05	0.000253	CcSEcCtD
Flurbiprofen—Vertigo—Epirubicin—peripheral nervous system neoplasm	5.81e-05	0.000253	CcSEcCtD
Flurbiprofen—Syncope—Epirubicin—peripheral nervous system neoplasm	5.8e-05	0.000253	CcSEcCtD
Flurbiprofen—Leukopenia—Epirubicin—peripheral nervous system neoplasm	5.79e-05	0.000252	CcSEcCtD
Flurbiprofen—Palpitations—Epirubicin—peripheral nervous system neoplasm	5.71e-05	0.000249	CcSEcCtD
Flurbiprofen—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	5.68e-05	0.000248	CcSEcCtD
Flurbiprofen—Cough—Epirubicin—peripheral nervous system neoplasm	5.64e-05	0.000246	CcSEcCtD
Flurbiprofen—Convulsion—Epirubicin—peripheral nervous system neoplasm	5.6e-05	0.000244	CcSEcCtD
Flurbiprofen—Nausea—Etoposide—peripheral nervous system neoplasm	5.59e-05	0.000244	CcSEcCtD
Flurbiprofen—Hypertension—Epirubicin—peripheral nervous system neoplasm	5.58e-05	0.000243	CcSEcCtD
Flurbiprofen—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	5.55e-05	0.000242	CcSEcCtD
Flurbiprofen—Anaemia—Doxorubicin—peripheral nervous system neoplasm	5.53e-05	0.000241	CcSEcCtD
Flurbiprofen—Myalgia—Epirubicin—peripheral nervous system neoplasm	5.5e-05	0.00024	CcSEcCtD
Flurbiprofen—Anxiety—Epirubicin—peripheral nervous system neoplasm	5.49e-05	0.000239	CcSEcCtD
Flurbiprofen—Discomfort—Epirubicin—peripheral nervous system neoplasm	5.44e-05	0.000237	CcSEcCtD
Flurbiprofen—Malaise—Doxorubicin—peripheral nervous system neoplasm	5.39e-05	0.000235	CcSEcCtD
Flurbiprofen—Dry mouth—Epirubicin—peripheral nervous system neoplasm	5.38e-05	0.000235	CcSEcCtD
Flurbiprofen—Vertigo—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	0.000234	CcSEcCtD
Flurbiprofen—Syncope—Doxorubicin—peripheral nervous system neoplasm	5.36e-05	0.000234	CcSEcCtD
Flurbiprofen—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	5.36e-05	0.000233	CcSEcCtD
Flurbiprofen—Confusional state—Epirubicin—peripheral nervous system neoplasm	5.32e-05	0.000232	CcSEcCtD
Flurbiprofen—Palpitations—Doxorubicin—peripheral nervous system neoplasm	5.29e-05	0.00023	CcSEcCtD
Flurbiprofen—Oedema—Epirubicin—peripheral nervous system neoplasm	5.28e-05	0.00023	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	5.28e-05	0.00023	CcSEcCtD
Flurbiprofen—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	5.26e-05	0.000229	CcSEcCtD
Flurbiprofen—Infection—Epirubicin—peripheral nervous system neoplasm	5.24e-05	0.000228	CcSEcCtD
Flurbiprofen—Cough—Doxorubicin—peripheral nervous system neoplasm	5.22e-05	0.000228	CcSEcCtD
Flurbiprofen—Shock—Epirubicin—peripheral nervous system neoplasm	5.19e-05	0.000226	CcSEcCtD
Flurbiprofen—Convulsion—Doxorubicin—peripheral nervous system neoplasm	5.18e-05	0.000226	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	5.17e-05	0.000225	CcSEcCtD
Flurbiprofen—Hypertension—Doxorubicin—peripheral nervous system neoplasm	5.17e-05	0.000225	CcSEcCtD
Flurbiprofen—Tachycardia—Epirubicin—peripheral nervous system neoplasm	5.15e-05	0.000224	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	5.1e-05	0.000222	CcSEcCtD
Flurbiprofen—Myalgia—Doxorubicin—peripheral nervous system neoplasm	5.09e-05	0.000222	CcSEcCtD
Flurbiprofen—Anxiety—Doxorubicin—peripheral nervous system neoplasm	5.08e-05	0.000221	CcSEcCtD
Flurbiprofen—Discomfort—Doxorubicin—peripheral nervous system neoplasm	5.03e-05	0.000219	CcSEcCtD
Flurbiprofen—Anorexia—Epirubicin—peripheral nervous system neoplasm	5.03e-05	0.000219	CcSEcCtD
Flurbiprofen—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	4.98e-05	0.000217	CcSEcCtD
Flurbiprofen—Hypotension—Epirubicin—peripheral nervous system neoplasm	4.93e-05	0.000215	CcSEcCtD
Flurbiprofen—Confusional state—Doxorubicin—peripheral nervous system neoplasm	4.92e-05	0.000215	CcSEcCtD
Flurbiprofen—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	4.88e-05	0.000213	CcSEcCtD
Flurbiprofen—Oedema—Doxorubicin—peripheral nervous system neoplasm	4.88e-05	0.000213	CcSEcCtD
Flurbiprofen—Infection—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.000211	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	4.81e-05	0.00021	CcSEcCtD
Flurbiprofen—Shock—Doxorubicin—peripheral nervous system neoplasm	4.8e-05	0.000209	CcSEcCtD
Flurbiprofen—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	4.78e-05	0.000208	CcSEcCtD
Flurbiprofen—Insomnia—Epirubicin—peripheral nervous system neoplasm	4.77e-05	0.000208	CcSEcCtD
Flurbiprofen—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	4.77e-05	0.000208	CcSEcCtD
Flurbiprofen—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	4.74e-05	0.000206	CcSEcCtD
Flurbiprofen—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	4.72e-05	0.000206	CcSEcCtD
Flurbiprofen—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	4.7e-05	0.000205	CcSEcCtD
Flurbiprofen—Somnolence—Epirubicin—peripheral nervous system neoplasm	4.69e-05	0.000204	CcSEcCtD
Flurbiprofen—Anorexia—Doxorubicin—peripheral nervous system neoplasm	4.65e-05	0.000203	CcSEcCtD
Flurbiprofen—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.64e-05	0.000202	CcSEcCtD
Flurbiprofen—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	4.59e-05	0.0002	CcSEcCtD
Flurbiprofen—Hypotension—Doxorubicin—peripheral nervous system neoplasm	4.56e-05	0.000199	CcSEcCtD
Flurbiprofen—Pain—Epirubicin—peripheral nervous system neoplasm	4.51e-05	0.000197	CcSEcCtD
Flurbiprofen—Constipation—Epirubicin—peripheral nervous system neoplasm	4.51e-05	0.000197	CcSEcCtD
Flurbiprofen—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.45e-05	0.000194	CcSEcCtD
Flurbiprofen—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.42e-05	0.000192	CcSEcCtD
Flurbiprofen—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.38e-05	0.000191	CcSEcCtD
Flurbiprofen—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	4.35e-05	0.00019	CcSEcCtD
Flurbiprofen—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	4.35e-05	0.00019	CcSEcCtD
Flurbiprofen—Somnolence—Doxorubicin—peripheral nervous system neoplasm	4.34e-05	0.000189	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.31e-05	0.000188	CcSEcCtD
Flurbiprofen—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.3e-05	0.000187	CcSEcCtD
Flurbiprofen—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.24e-05	0.000185	CcSEcCtD
Flurbiprofen—Urticaria—Epirubicin—peripheral nervous system neoplasm	4.19e-05	0.000183	CcSEcCtD
Flurbiprofen—Constipation—Doxorubicin—peripheral nervous system neoplasm	4.18e-05	0.000182	CcSEcCtD
Flurbiprofen—Pain—Doxorubicin—peripheral nervous system neoplasm	4.18e-05	0.000182	CcSEcCtD
Flurbiprofen—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	4.17e-05	0.000182	CcSEcCtD
Flurbiprofen—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	4.17e-05	0.000182	CcSEcCtD
Flurbiprofen—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.02e-05	0.000175	CcSEcCtD
Flurbiprofen—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	3.99e-05	0.000174	CcSEcCtD
Flurbiprofen—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	3.89e-05	0.000169	CcSEcCtD
Flurbiprofen—Urticaria—Doxorubicin—peripheral nervous system neoplasm	3.88e-05	0.000169	CcSEcCtD
Flurbiprofen—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.86e-05	0.000168	CcSEcCtD
Flurbiprofen—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	3.86e-05	0.000168	CcSEcCtD
Flurbiprofen—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.79e-05	0.000165	CcSEcCtD
Flurbiprofen—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.73e-05	0.000163	CcSEcCtD
Flurbiprofen—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.61e-05	0.000157	CcSEcCtD
Flurbiprofen—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.6e-05	0.000157	CcSEcCtD
Flurbiprofen—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.5e-05	0.000153	CcSEcCtD
Flurbiprofen—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.49e-05	0.000152	CcSEcCtD
Flurbiprofen—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.45e-05	0.000151	CcSEcCtD
Flurbiprofen—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.36e-05	0.000146	CcSEcCtD
Flurbiprofen—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.34e-05	0.000146	CcSEcCtD
Flurbiprofen—Rash—Epirubicin—peripheral nervous system neoplasm	3.33e-05	0.000145	CcSEcCtD
Flurbiprofen—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.32e-05	0.000145	CcSEcCtD
Flurbiprofen—Headache—Epirubicin—peripheral nervous system neoplasm	3.31e-05	0.000144	CcSEcCtD
Flurbiprofen—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.23e-05	0.000141	CcSEcCtD
Flurbiprofen—Nausea—Epirubicin—peripheral nervous system neoplasm	3.13e-05	0.000137	CcSEcCtD
Flurbiprofen—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.1e-05	0.000135	CcSEcCtD
Flurbiprofen—Rash—Doxorubicin—peripheral nervous system neoplasm	3.08e-05	0.000134	CcSEcCtD
Flurbiprofen—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.08e-05	0.000134	CcSEcCtD
Flurbiprofen—Headache—Doxorubicin—peripheral nervous system neoplasm	3.06e-05	0.000133	CcSEcCtD
Flurbiprofen—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.9e-05	0.000126	CcSEcCtD
